logo
Plus   Neg
Share
Email

Entellus Medical Agrees To Be Acquired By Stryker In $662 Mln Deal

Entellus Medical Inc. (ENTL) said that it agreed to be acquired by Stryker Corp. (SYK) for $24.00 per share in cash, or an equity value of about $662 million. The Entellus Board of Directors unanimously approved entering into the agreement.

The closing of this transaction is subject to approval by Entellus' stockholders, expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act and other customary closing conditions.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Swiss drug major Roche Holding AG reported Wednesday higher sales in its first nine months of fiscal 2018, with growth in Pharmaceuticals sales in all regions except Europe. Diagnostics Division also recorded higher sales in all regions. Looking ahead to fiscal 2018, Roche confirmed its outlook for higher results at constant exchange rates. Online-video streaming service Netflix Inc. (NFLX), Tuesday reported a third-quarter profit that surged from last year as revenues increased 34% driven largely by strong subscriber additions. Shares surged nearly 12 percent in the after-hours trading. Netflix added 6.96 million subscribers globally... Despite opposition from the pharmaceutical industry, President Donald Trump's administration has proposed a new rule requiring companies to include the prices for prescription drug and biological products in their television advertisements.
Follow RTT